DRUG SUBJECT TO SPECIAL CONTROL PRESCRIPTION IN A COUNTY OF SERIDÓ POTIGUAR, BRAZIL
Abstract
The prescription of medications constitutes a therapeutic intervention that must consider technical-legal and user-centered aspects to achieve effective therapy and patient safety. Thus, this study aimed to evaluate prescriptions of the subject to special control drugs in primary care in Caicó, RN, Brazil, based on the legislation in force, through a cross-sectional, descriptive- exploratory, quantitative study, based on the special control prescription prepared by physicians during the period from July 2018 to June 2019, at the municipal Pharmaceutical Supply Center. Pharmacological classification of prescription drugs was also analyzed and their compliance with the Municipal List of Essential Medicines. In all, 1.682 prescriptions were evaluated; 1.7% of these were eliminated due to readability issues, meaning they already were legislation non-compliant. There was a predominance of non-compliant prescriptions (99.77%), whose items duration of treatment (97.1%), route of administration (89.3%), and drug nomenclature by active ingredient (14.6%) were the most prevalent regarding these non-conformities. As for the pharmacological classes of the prescribed drugs, benzodiazepine anxiolytics predominated (30.97%). All prescription drugs complied with the municipal essential drug list. There is a need to reorient medical professional training, through insertion and/or emphasis on strategies for preparing prescriptions in compliance with technical-legal and user-centered precepts, in addition to interprofessional education and work, in order to contribute to user-centered assistance, improved patient safety, access, and effectiveness in the context of health care.
Keywords
Full Text:
PDF (Português (Brasil))DOI: http://dx.doi.org/10.14450/2318-9312.v33.e2.a2021.pp167-174
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Lucas Soares da Nóbrega Silva, Maria Vitória Ideão Leite da Rocha, Almária Mariz Batista
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Infarma - Ciências Farmacêuticas
ISSN - 2318-9312 (Versão eletrônica)
ISSN - 0104-0219 (Versão impressa)
Conselho Federal de Farmácia - CFF
SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF
CEP: 71635-615 - Fone: (61)3878-8751
e-mail:infarma@cff.org.br
Diretoria
Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia
Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia
João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia
Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia